Tyrosine Phosphorylation of Pyk2 Is Selectively Regulated by Fyn During TCR Signaling by Qian, Dapeng et al.
 
1253
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/97/04/1253/07 $2.00
Volume 185, Number 7, April 7, 1997 1253–1259
 
Tyrosine Phosphorylation of Pyk2 Is Selectively
Regulated by Fyn During TCR Signaling
 
By Dapeng Qian,
 
*
 
 Sima Lev,
 
‡
 
 Nicolai S.C. van Oers,
 
*
 
 Ivan Dikic,
 
§
 
 
Joseph Schlessinger,
 
§
 
 and Arthur Weiss
 
*
 
From the 
 
*
 
Howard Hughes Medical Institute, Departments of Medicine and of Microbiology and 
Immunology, University of California, San Francisco, California 94143; 
 
‡
 
SUGEN, Redwood City, 
California 94063; and 
 
§
 
the Department of Pharmacology, New  York University Medical Center,
New York  10016
 
Summary
 
The Src family protein tyrosine kinases (PTKs), Lck and Fyn, are coexpressed in T cells and
perform crucial functions involved in the initiation of T cell antigen receptor (TCR) signal
transduction. However, the mechanisms by which Lck and Fyn regulate TCR signaling are
still not completely understood. One important question is whether Lck and Fyn have specific
targets or only provide functional redundancy during TCR signaling. We have previously
shown that Lck plays a major role in the tyrosine phosphorylation of the TCR-
 
z
 
 chain and the
ZAP-70 PTK. In an effort to identify the targets that are specifically regulated by Fyn, we have
studied the tyrosine phosphorylation of Pyk2, a recently discovered new member of the focal
adhesion kinase family PTK. We demonstrated that Pyk2 was rapidly tyrosine phosphorylated
following TCR stimulation. TCR-induced tyrosine phosphorylation of Pyk2 was selectively
dependent on Fyn but not Lck. Moreover, in heterologous COS-7 cells, coexpression of Pyk2
with Fyn but not Lck resulted in substantial increases in Pyk2 tyrosine phosphorylation. The
selective regulation of Pyk2 tyrosine phosphorylation by Fyn in vivo correlated with the pref-
erential phosphorylation of Pyk2 by Fyn in vitro. Our results demonstrate that Pyk2 is a spe-
cific target regulated by Fyn during TCR signaling.
 
E
 
ngagement of the TCR evokes a series of signal trans-
duction events critical for the functional activation of
T cells (reviewed in reference 1). Signal transduction through
the TCR is also important for T cell development (1). The
earliest detectable signaling event after TCR stimulation is
the activation of protein tyrosine kinases (PTKs)
 
1
 
, resulting
in the tyrosine phosphorylation of cellular proteins (1). Lck
and Fyn, two cytoplasmic PTKs of the Src family, have
been implicated as the initiating PTKs for TCR signaling.
Lck is critical for TCR signaling. Mutant T cell lines lack-
ing functional Lck or T cells from 
 
lck
 
2
 
/
 
2
 
 mice respond to
TCR stimulation with very limited tyrosine phosphoryla-
tion of cellular proteins, greatly decreased calcium mobili-
zation, and reduced proliferation (2–4). Lck also plays a
critical role in T cell development, as 
 
lck
 
2
 
/
 
2
 
 mice have a
pronounced reduction in thymocyte numbers and a block in
thymocyte development at the early CD4
 
1
 
CD8
 
1
 
 stage (2).
The residual progression of thymocytes from CD4
 
2
 
CD8
 
2
 
to CD4
 
1
 
CD8
 
1
 
 stage in 
 
lck
 
2
 
/
 
2
 
 mice depends upon the re-
dundant function of Fyn. Combined disruption of both
Lck and Fyn (
 
lck
 
2
 
/
 
2
 
/
 
fyn
 
2
 
/
 
2
 
) completely arrests thymocyte
development at the CD4
 
2
 
CD8
 
2
 
 stage (5, 6). Fyn is also
important for TCR signaling. Mature CD4
 
1
 
 and CD8
 
1
 
 thy-
mocytes from 
 
fyn
 
2
 
/
 
2
 
 mice are severely impaired in TCR
signaling as measured by calcium mobilization, protein ty-
rosine phosphorylation, IL-2 production, and proliferation
(7, 8). Peripheral T cells from 
 
fyn
 
2
 
/
 
2
 
 mice are also impaired
in TCR signaling, albeit to a lesser degree (7, 8).
The mechanisms by which Lck or Fyn regulates proxi-
mal TCR signaling are still not completely understood.
One important issue is whether Lck and Fyn have specific
targets or only provide functional redundancy during TCR
signaling. We have studied the TCR signaling pathway in
T cells from 
 
lck
 
2
 
/
 
2
 
 or 
 
fyn
 
2
 
/
 
2
 
 mice in an attempt to identify
targets for Lck and Fyn. We have shown previously that
Lck is the primary PTK that regulates the tyrosine phos-
phorylation of the TCR subunits and of ZAP-70 (9), a Syk
family PTK critical for TCR signaling (reviewed in refer-
ence 10). The identity of the downstream target(s) for Fyn
has not been identified. In the present study, we have fo-
cused our efforts in identifying target(s) whose phosphory-
lation is specifically regulated by Fyn. Previous studies have
shown that Fyn interacts with a number of proteins in T cells
(11–16), including several proteins migrating from 110 to
 
1
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 FAK, focal adhesion kinase; PTK, protein
tyrosine kinase; ZAP-70, 
 
z
 
-associated protein 70.
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130 kD. These proteins are potential targets for Fyn, though
their identities have not been fully elucidated. A recently
discovered cytoplasmic PTK Pyk2 has a molecular mass of
112 kD (17–19). Pyk2 is a member of the focal adhesion
kinase (FAK) family and has been shown to play important
roles in signal transduction of neuronal cells (17, 20, 21).
Because Pyk2 is also expressed in T cells (18, 19), we ex-
amined whether it might be a target for Fyn during TCR
signaling. Our data demonstrate that Pyk2 is a novel Fyn-
dependent tyrosine-phosphorylated substrate during TCR
signaling.
 
Materials and Methods
 
Mice.
 
Wild-type mice (C57BL/6 strain) were purchased
from The Jackson Laboratory (Bar Harbor, ME). 
 
lck
 
2
 
/
 
2
 
 mice (2)
and 
 
fyn
 
2
 
/
 
2
 
 mice (7) were obtained from Drs. T. Mak (Amgen
and the Ontario Cancer Institute, Toronto, Ontario, Canada) and
R. Perlmutter (University of Washington, Seattle, WA), respec-
tively.
 
Cells.
 
Preparation of thymocytes and lymph node T cells
were carried out as described (9). Jurkat, the human leukemic T cell
line, was described previously (3). COS-7 cells (derived from
monkey kidney), which do not express Lck, Fyn (T), ZAP-70,
and Pyk2 endogenously, have been described (22). TAg Jurkat
cells, obtained from Dr. G. Crabtree (Stanford University, Palo Alto,
CA), are Jurkat T cells stably transfected with SV40 TAg.
 
Antibodies.
 
Anti-CD3 mAb 145-2C11 was obtained from the
American Type Culture Collection ([ATCC] Rockville, MD).
C305 is an anti-TCR mAb. The anti–ZAP-70 mAb 2F3 was de-
scribed (22). The rabbit anti–ZAP-70 antiserum no. 1598 and the
anti–ZAP-70 mAb 1E7.2 were produced against a KLH–peptide
immunogen with a peptide corresponding to the human ZAP-70
amino acid sequence 282–307. Antibodies against Pyk2 were
raised in rabbits immunized against a synthetic peptide corre-
sponding to 15 amino-terminal residues (D1) (17) or with GST
fusion protein containing amino acids 362–647 (antibody nos. 1
and 3) (17) or 679–830 (antibody no. 600) (21) of Pyk2. The rab-
bit anti-Fyn antibody and the anti-Lck mAb 1F6 were obtained
from Drs. A. Veillette (McGill University, Montreal, Canada) and
J. Bolen (DNAX Research Institute, Palo Alto, CA), respec-
tively. The rabbit anti-Lck antibody was generated using a TrpE
fusion protein containing the amino-terminal unique region of
Lck as an immunogen. The anti-Fyn mAb was obtained from
Transduction Laboratories, Lexington, KY. 12CA5 (Boehringer
Mannheim, Indianapolis, IN) is a murine mAb to the hemagglu-
tinin (HA) epitope. OKT8, obtained from ATCC, is a murine
mAb to the CD8-
 
a
 
 chain. Anti-phosphotyrosine mAbs 4G10 and
RC20 were obtained from Upstate Biotechnology, Lake Placid,
NY and Transduction Laboratories, respectively.
 
Plasmids.
 
Lck and Fyn (T) were expressed with the pSM vec-
tor and pSV7d vector, respectively, as described (22). pSM was de-
rived from pSV7d. Pyk2 and PKM, a kinase-inactive Pyk2
mutant, were expressed with the pRK5 vector (17, 20). ZAP-70
(K369A) was expressed with the pBJ1 vector (23). HA–Pyk2 was
created by fusing the HA-epitope tag (YPYDVPDYAS) to the
carboxy-terminal end of Pyk2 and subcloned into pRK5 vector.
 
Stimulation, Solubilization, Immunoprecipitation, and Immunoblot
Analysis.
 
Stimulation of mouse thymocytes and T cells with 10
 
m
 
g/ml purified anti-CD3 mAb 145-2C11 was carried out as de-
scribed (9). Stimulation of Jurkat with the anti-TCR mAb C305
or 1 
 
m
 
M ionomycin was performed as described (3). Cells were
lysed in a buffer containing 1% NP-40, 10 mM Tris, pH 7.6, 150
mM NaCl, 2 mM EDTA, protease and phosphatase inhibitors, as
described (3). Immunoprecipitation, immunoblotting, stripping,
and  reprobing blots were performed as described (23).
 
Transfections.
 
COS-7 cells were transiently transfected with 2
 
m
 
g of each construct using DEAE–dextran (22). The total amount
of DNA for each transfection was equalized with vector DNA.
Cells were harvested 72 h after transfection and lysed with the ly-
sis buffer as described above. Transient transfection of TAg Jurkat
cells with 40 
 
m
 
g pRK5.HA–Pyk2 expression construct and stim-
ulation of transfected cells were carried out as described (23).
 
Kinase Assays.
 
For in vitro kinase reactions using poly(Glu:
Tyr) (4:1) as an exogenous substrate, immunoprecipitates were
washed three times with the RIPA buffer (1% NP-40, 1% deoxy-
Figure 1. (A) Lck and Fyn regulate TCR stimulation–induced tyrosine
phosphorylation of shared and distinct substrates. Thymocytes isolated
from wild-type (Wt), lck2/2, or fyn2/2 mice were either left unstimulated
(2) or stimulated (1) with the anti-CD3 mAb 145-2C11 for 3 min. Cells
were lysed, and tyrosine phosphorylation of whole cell lysates was ana-
lyzed by immunoblotting with the anti-phosphotyrosine (anti–P-Tyr)
mAb 4G10. The migration of tyrosine-phosphorylated TCR-z chain is
indicated. Molecular mass markers are also indicated. (B) Tyrosine phos-
phorylation of ZAP-70 requires Lck but not Fyn. Thymocytes isolated
from wild-type (Wt), lck2/2, or fyn2/2 mice were either left unstimulated
or stimulated with the anti-CD3 mAb for 3 min. Cells were lysed, ZAP-
70 was immunoprecipitated (IP) with an anti–ZAP-70 mAb (1E7.2), and
analyzed by anti–P-Tyr immunoblotting using mAb 4G10. The same blot
was stripped and reprobed with anti–ZAP-70 (mAb 1E7.2). 
1255
 
Qian et al.
lcholate, 0.1% SDS, 50 mM Tris, pH 7.6, 150 mM NaCl, 5 mM
EDTA, and protease and phosphatase inhibitors), once with the
RIPA buffer without EDTA, once with the kinase buffer I (50 mM
Tris, pH 7.6, 5 mM MnCl
 
2
 
, 5 mM MgCl
 
2
 
), and incubated with
30 
 
m
 
l kinase buffer I containing 20 
 
m
 
g poly(Glu/Tyr) (4:1) (Sigma)
and 10 
 
m
 
Ci 
 
g
 
-[
 
32
 
P]ATP (6,000 Ci mmol
 
2
 
1
 
; Amersham) for 12.5
min at room temperature. The reactions were stopped with SDS
sample buffer and resolved on SDS-PAGE (10% gel). Autorad-
iography and quantitation of the kinase activity were performed
as described (17). For in vitro kinase reactions using purified Lck
or Fyn (Upstate Biotechnology, Lake Placid, NY), immunopre-
cipitates were washed three times with the RIPA buffer, once with
the RIPA buffer without EDTA, once with the kinase buffer II
(20 mM Hepes, pH 7.4, 100 mM NaCl, 5 mM MnCl
 
2
 
, 5 mM
MgCl
 
2
 
), and incubated with 30 
 
m
 
l kinase buffer II containing 3 U
purified kinase (1 U is defined as 1 pmol phosphate transferred to
a cdc2 [6–20] peptide min
 
2
 
1
 
 mg protein
 
2
 
1
 
), 1 
 
m
 
M cold ATP, and
10 
 
m
 
Ci 
 
g
 
-[
 
32
 
P]ATP for 10 min at room temperature. The reac-
tions were stopped with SDS sample buffer and resolved on SDS-
PAGE.
 
Results and Discussion
 
Lck and Fyn Regulate the Tyrosine Phosphorylation of Shared
and Distinct Substrates.
 
To determine whether Lck and
Fyn have specific targets or only provide functional redun-
dancy during TCR signaling, we first examined the induc-
tion of tyrosine-phosphorylated proteins after TCR stimu-
lation in thymocytes isolated from wild-type, 
 
lck
 
2
 
/
 
2
 
, or
 
fyn
 
2
 
/
 
2
 
 mice (Fig. 1 
 
A
 
). TCR stimulation–induced tyrosine
phosphorylation of cellular proteins was generally decreased
in thymocytes isolated from either 
 
lck
 
2
 
/
 
2
 
 or 
 
fyn
 
2
 
/
 
2
 
 mice
compared with those from wild-type mice. More impor-
tantly, reductions in tyrosine phosphorylation of different
proteins were evident. These results suggest that Lck and
Fyn regulate the tyrosine phosphorylation of shared and dis-
tinct substrates. We have already shown (9) and confirm here
that Lck is the primary Src family PTK regulating the ty-
rosine phosphorylation of the TCR-
 
z
 
 chain and ZAP-70,
whereas Fyn has only a minor redundant role in regulating
these events (Fig. 1, 
 
A
 
 and 
 
B
 
).
 
Pyk2 Is a Novel Tyrosine-phosphorylated Substrate after TCR
Stimulation.
 
To determine whether Pyk2 is a target for
Fyn during TCR signaling, we first tested whether Pyk2 be-
comes tyrosine phosphorylated upon TCR stimulation.
We found that Pyk2 was weakly tyrosine phosphorylated at
basal state in T cells. Stimulation of the TCR resulted in a
rapid increase in Pyk2 tyrosine phosphorylation in human
Jurkat T cells (Fig. 2 
 
A
 
, 
 
left
 
) or in normal mouse thymo-
cytes and lymph node T cells (Fig. 2 
 
B). Enhanced tyrosine
phosphorylation of Pyk2 is relatively specific to TCR stim-
ulation, as activation via Fas or the costimulator receptor
CD28 did not lead to increased Pyk2 tyrosine phosphoryla-
tion (data not shown). Furthermore, in contrast with other
Figure 2. Fyn, but not Lck, is
required for TCR-stimulated
Pyk2 tyrosine phosphorylation.
(A) Pyk2 phosphorylation in Jur-
kat T cells. Left, Jurkat cells were
stimulated with anti-TCR
(mAb C305) for the indicated
period of times. Right, Jurkat
cells were stimulated with anti-
TCR or ionomycin (IONO) for
2 min. Cells were lysed, Pyk2
was immunoprecipitated with
anti-Pyk2 (antibody no. 3), and
analyzed by immunoblotting us-
ing anti–P-Tyr mAb RC20. The
level of Pyk2 in each sample was
verified either by immunoblot-
ting an aliquot of anti-Pyk2 im-
munoprecipitates with anti-
Pyk2 (antibody no. 3) (left) or by
stripping and reprobing the same
blot with anti-Pyk2 (right). (B)
Thymocytes isolated from wild-
type (Wt), lck2/2, or fyn2/2 mice
were either left unstimulated or
stimulated with the anti-CD3
mAb for 3 min. Cells were lysed,
Pyk2 was immunoprecipitated
with anti-Pyk2 (antibody no.
600), and analyzed by immuno-
blotting using anti-P-Tyr mAb
4G10. The same blot was
stripped and reprobed with anti-
Pyk2 (antibody no. 3).1256 Pyk and Fyn in TCR Signaling
systems, such as the nicotinic acetylcholine receptor ex-
pressed in neuronal cells, which induce Pyk2 tyrosine phos-
phorylation by stimulation of extracellular calcium influx
(17, 20, 24), TCR-induced tyrosine phosphorylation of Pyk2
is Ca21 independent. Treatment of Jurkat T cells (Fig. 2 A,
right) or mouse thymocytes (data not shown) with the cal-
cium ionophore, ionomycin, did not stimulate Pyk2 tyrosine
phosphorylation. Moreover, EGTA had no effect on TCR-
stimulated Pyk2 tyrosine phosphorylation in these cells (data
not shown). Thus, Pyk2 tyrosine phosphorylation is likely
to be an event proximal to Ca21 mobilization during TCR
signaling. Together, these results demonstrate that Pyk2 is a
Figure 3. Pyk2 activation is selectively induced by Fyn, but not Lck. (A) Tyrosine phosphorylation of Pyk2. Pyk2 or the kinase-inactive ZAP-70 mu-
tant, ZAP-70 (K369A), was transiently cotransfected with vector, Lck, or Fyn (T) into COS-7 cells. Tyrosine phosphorylation of Pyk2 or ZAP-70
(K369A) was determined by immunoblotting using anti–P-Tyr mAb 4G10 (right), after immunoprecipitation with anti-Pyk2 (antibody no. 1) or anti–
ZAP-70 (antibody no. 1598). The expression of Pyk2, ZAP-70 (K369A), Fyn (T), or Lck in each transfected sample was determined by immunoblotting
whole cell lysates with anti-Pyk2 (antibody no. 1), anti–ZAP-70 (mAb 2F3), a rabbit anti-Fyn antibody, or anti-Lck (mAb 1F6) (left). (B) Phosphoryla-
tion of an exogenous substrate by Pyk2. Pyk2 was transiently transfected into COS-7 cells with vector, Lck, or Fyn (T). Cells were lysed, and Pyk2 was im-
munoprecipitated with anti-Pyk2 (antibody no. 600). The immunoprecipitates were extensively washed with RIPA buffer, and subjected to kinase reactions
in vitro in the presence of g-[32P]ATP and the exogenous substrate poly(Glu/Tyr) (4:1). The phosphorylated products were resolved by SDS-PAGE, an-
alyzed by autoradiography (top), and quantitated by a phosphorimager and Image Quant software (Molecular Dynamics). The kinase activities relative to
vector cotransfected cells are indicated (middle). The expression of Pyk2 in each sample was determined by immunoblotting whole cell lysates with anti-
Pyk2 (antibody no. 1) (bottom). (C) The kinase activity of Pyk2 is required for the ability of Pyk2 to phosphorylate an exogenous substrate but not Pyk2
tyrosine phosphorylation induced by Fyn (T). Pyk2 or the kinase inactive mutant Pyk2 with a point mutation at the ATP-binding site (PKM) was
cotransfected with Fyn (T) into COS-7 cells. Cells were lysed, and Pyk2 or PKM was immunoprecipitated with anti-Pyk2 (antibody no. 600). Phos-
phorylation of poly(Glu/Tyr) (4:1) by the immunoprecipitates in in vitro kinase reactions was determined (left). The relative kinase activities to Pyk2 and
vector cotransfected cells (data not shown) are also indicated. Tyrosine phosphorylation of Pyk2 and PKM was analyzed by immunoblotting using anti–
P-Tyr mAb 4G10 (right). The expression of Pyk2, PKM, or Fyn (T) in each transfected sample was determined by immunoblotting whole cell lysates
with the anti-Pyk2 (antibody no. 1) or an anti-Fyn mAb. (D) Phosphorylation of PKM by purified Lck or Fyn. COS-7 cells transfected with PKM were
lysed, and lysates were immunoprecipitated with either normal rabbit serum (NRS) or an affinity-purified anti-Pyk2 (antibody D1). The immunoprecip-
itates were extensively washed with RIPA buffer and used in in vitro kinase reactions in the absence (2) or presence (1) of purified Lck or Fyn (3 U/re-
action).1257 Qian et al.
newly identified physiological target of activated PTK(s) af-
ter TCR stimulation.
Tyrosine Phosphorylation of Pyk2 during TCR Signaling Is
Fyn Dependent. We compared the status of Pyk2 tyrosine
phosphorylation in thymocytes and T cells isolated from
lck2/2 or fyn2/2 mice with those from wild-type mice (Fig.
2 B). Because lck2/2 mice have few peripheral T cells, we
focused our analysis on thymocytes. Pyk2 tyrosine phos-
phorylation was readily detected after TCR stimulation in
thymocytes isolated from lck2/2 mice. In contrast, thy-
mocytes and lymph node T cells from fyn2/2 mice exhib-
ited little, if any, detectable basal and TCR-stimulated Pyk2
tyrosine phosphorylation. This experiment provides strong
genetic evidence that Fyn, but not Lck, is required for ty-
rosine phosphorylation of Pyk2 during TCR signaling.
Selective Regulation of Pyk2 Tyrosine Phosphorylation and
Activation by Fyn in COS-7 Cells. Because it is possible
that the differences in Pyk2 phosphorylation observed in
lck2/2 and fyn2/2 thymocytes might reflect heterogeneity
in the cellular subsets in these mice, the regulation of ty-
rosine phosphorylation of Pyk2 by Lck and Fyn was further
studied in a heterologous cell system, COS-7 cells. Co-
transfection of Pyk2 with the lymphocyte-specific form of
Fyn, Fyn (T), resulted in a marked increase in Pyk2 ty-
rosine phosphorylation (Fig. 3 A, right). Hence, overex-
pression of Fyn (T) in the absence of other lymphoid-spe-
cific components in COS-7 cells is sufficient to induce
Pyk2 tyrosine phosphorylation. Cotransfection with Lck only
led to a slight increase in Pyk2 tyrosine phosphorylation.
However, Lck induced substantial tyrosine phosphorylation
of a kinase-inactive ZAP-70 mutant, ZAP-70 (K369A), even
when expressed at a lower level (Fig. 3 A). Cotransfection
of Pyk2 with Fyn (T), but not Lck, also enhanced the ki-
nase activity of Pyk2 towards the exogenous substrate, poly
(Glu/Tyr) (4:1) (Fig. 3 B). Mutation of the ATP-binding
site in the kinase domain abolished the kinase activity of
Pyk2 (Fig. 3 C, left), but had no effect on the overall ty-
rosine phosphorylation of Pyk2 induced by cotransfection
with Fyn (T) (Fig. 3 C, right). Thus, the kinase activity of
Pyk2 is not required for its tyrosine phosphorylation in-
duced by Fyn (T) in these cotransfection experiments.
Taken together, these results further demonstrate that Pyk2
tyrosine phosphorylation or activation is selectively regu-
lated by Fyn, but not Lck.
Pyk2 Is a Preferred Substrate for Fyn In Vitro. The appar-
ent differential regulation of Pyk2 tyrosine phosphorylation
or activation by Lck and Fyn suggests that Pyk2 may be a
preferred substrate for Fyn but not Lck. To determine
whether Fyn or Lck could phosphorylate Pyk2, we immu-
noprecipitated the kinase-inactive Pyk2 mutant, PKM (17),
that had been transfected into COS-7 cells and subjected it
to kinase reactions in vitro with either purified Fyn or Lck
(Fig. 3 D). When the same specific activities of Fyn and
Lck were used in each reaction, PKM was strongly phos-
phorylated by Fyn. In contrast, little or no phosphorylation
of PKM was induced by Lck. Thus, Pyk2 is a preferred
substrate for Fyn in vitro.
Association of Pyk2 with Fyn and Lck in T Cells. Next, we
examined whether Fyn or Lck may interact with Pyk2 in T
cells as determined by coimmunoprecipitation. Anti-Fyn
antibodies coimmunoprecipitated comparable levels of Pyk2
from thymocytes of C57BL/6 mice before and after TCR
stimulation (Fig. 4 A). However, anti-Pyk2 antibodies did
not coimmunoprecipitate Fyn from mouse thymocytes
(data not shown). This likely results from the disruption of
association by antibody binding. To circumvent this prob-
lem, we introduced a HA tag into the carboxyl terminus of
Pyk2 and then transfected the HA-tagged Pyk2 into TAg
Jurkat T cells. Similar levels of Fyn were coimmunoprecip-
itated by anti-HA antibodies from HA–Pyk2-transfected
TAg Jurkat cells before and after TCR stimulation (Fig. 4
B). These data indicate that Fyn constitutively associates
with Pyk2 in T cells. Interestingly, anti-Lck antibodies also
coimmunoprecipitated Pyk2 from mouse thymocytes be-
fore and after TCR stimulation (Fig. 4 A). This result is
consistent with an association between Fyn and Lck that
was reported previously (25). It is possible that Pyk2 is
present in the same multimolecular complex containing
both Fyn and Lck. However, because Pyk2 is a preferred
substrate for Fyn, it is selectively phosphorylated or acti-
vated by Fyn, but not Lck.
In summary, our results demonstrate that Pyk2 is selec-
tive target regulated by Fyn during TCR signaling. This
selectivity is due, at least in part, to the fact that Pyk2 is a
Figure 4. Physical association of Fyn with Pyk2 in T cells. (A) Thy-
mocytes isolated from C57BL/6 mice were either left unstimulated or
stimulated with the anti-CD3 mAb for 3 min. Cells were lysed, lysates
were immunoprecipitated with NRS, a rabbit anti-Fyn antibody, or a
rabbit anti-Lck antibody, and analyzed by immunoblotting with an affinity-
purified anti-Pyk2 (antibody D1), an anti-Fyn mAb, and anti-Lck (mAb
1F6). (B) HA-tagged Pyk2 was transiently transfected into TAg Jurkat T
cells. 40 h later, transfected cells were either left unstimulated or stimu-
lated with anti-TCR (mAb C305) for 2 min. Cells were lysed, lysates were
immunoprecipitated with either a control (Ctrl) antibody (OKT8) or anti-
HA (mAb 12CA5), and analyzed by immunoblotting with an anti-HA
mAb (12CA5) and an anti-Fyn mAb. The positions of HA–Pyk2 and Fyn
are indicated by arrows.1258 Pyk and Fyn in TCR Signaling
preferred substrate for Fyn in vitro. Also, these findings
provide evidence that Lck and Fyn have functional speci-
ficities during TCR signaling. Activation of distinct targets
by Lck and Fyn may allow for the differential control of
downstream signaling pathways by the TCR. Alternatively,
full activation of a critical downstream signaling compo-
nent may require synergism between two distinct upstream
activating pathways regulated by TCR®Lck®ZAP-70
and TCR®Fyn®Pyk2. The defective TCR signaling re-
sponses in lck2/2 and fyn2/2 mice may result, in part, from
the failure of ZAP-70 and Pyk2 to be activated, respec-
tively. Further identification of other targets for Lck and
Fyn, as well as the targets for ZAP-70 and Pyk2, should
help clarify how these cytoplasmic PTKs coordinately medi-
ate TCR signaling.
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